ASTERDM · Healthcare
Aster DM Quality Care Ltd. reported revenue of ₹1,197 cr for July to September 2025, +10.2% on the year and +11.0% on the quarter. It is the highest quarterly revenue in the last 10 quarters on record. Over the last four quarters revenue comes to ₹4,325 cr, +7.7% on the four before.
Operating profit (EBITDA) was ₹236 cr, a margin of 19.7%, −27 bps on the year and +98 bps on the quarter. Over the last 8 quarters the margin has ranged from 15.6% to 20.0%, averaging 17.8%. Operating costs grew +10.6%, broadly with revenue, so operating profit kept pace with sales.
Net profit was ₹121 cr, +14.2% on the year and +28.7% on the quarter, with earnings per share of ₹2.12. Profit before other income, one-offs and tax grew 12.1%, so the profit growth came from the business itself. The tax rate was 27% against an average of 19% over the previous 6 quarters, which weighed on profit this quarter. Profit over the last four quarters totals ₹365 cr, −93.3% on the four before.
On earnings per share of ₹6.49 over the last four quarters, the stock at ₹674.95 trades at 104.0 times trailing earnings.
Written from the quarterly statements. The filing read adds the balance sheet and cash flow filed with this quarter, the auditor's review, segment results, one-off items line by line and what management said on the call.
No check fired. That is a statement about the checks below, not a verdict on the company.
Could not run on this quarter: Exceptional items that recur, Cash behind the profit, Receivables against sales, Inventory against sales, Borrowing while holding cash, Auditor's review or audit report, IPO money used as stated, Related-party transactions, Exits, postponements, restatements, Promoter pledges and allotments, Earlier promises against delivery, When the results were filed. Most need the filing read (balance sheet, cash flow, auditor, disclosures).
Net profit a year ago, each driver's change, and net profit now. Blue added profit, red took it away.
This quarter's filing carries a balance sheet and a cash flow statement. The cash, receivables and borrowing checks run once the filing read is in.
| Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ₹929 cr | ₹955 cr | ₹974 cr | ₹1,002 cr | ₹1,086 cr | ₹1,050 cr | ₹1,000 cr | ₹1,078 cr | ₹1,197 cr | ₹1,186 cr | ₹1,182 cr | ₹1,311 cr |
| YoY | — | — | — | +19% | +17% | +10% | +3% | +8% | +10% | +13% | +18% | +22% |
| EBITDA margin | 15.3% | 15.6% | 16.0% | 16.1% | 20.0% | 17.7% | 18.2% | 18.7% | 19.7% | 17.0% | 19.0% | 19.5% |
| Other income, % of PBT | — | 70% | −143% | 99% | 22% | 9% | 5% | 21% | 17% | 0% | 23% | −99% |
| Exceptional items | — | — | — | — | — | — | — | — | — | — | — | — |
| Tax rate | — | 5% | — | 1% | 33% | 37% | 6% | 31% | 27% | 43% | 6% | 62% |
| Net profit | −₹15.0 cr | ₹209 cr | −₹2.0 cr | ₹5,152 cr | ₹106 cr | ₹64.0 cr | ₹86.0 cr | ₹94.0 cr | ₹121 cr | ₹59.0 cr | ₹154 cr | ₹29.0 cr |
| YoY | — | — | — | +25,660% | — | −69% | — | −98% | +14% | −8% | +79% | −69% |
| Core profit YoY | — | — | — | +65% | +118% | +39% | +26% | +51% | +12% | +11% | +47% | +45% |
| EPS | −₹0.62 | ₹3.59 | −₹0.48 | ₹103.00 | ₹1.94 | ₹1.14 | ₹1.58 | ₹1.65 | ₹2.12 | ₹1.01 | ₹2.71 | ₹0.31 |
| Flags | · | 1 | · | 3 | ✓ | ✓ | 1 | ✓ | ✓ | ✓ | 2 | ✓ |
Each quarter is read with the same rules. Balance-sheet and cash checks run on half-year and annual quarters; filing-read checks run where a read exists.
Aster DM Quality Care Ltd. reported revenue of ₹1,197 cr (+10.2% on the year) and net profit of ₹121 cr (+14.2% on the year) for July to September 2025.
Profit before other income, exceptional items and tax moved +12.1% on the year, against +14.2% for reported profit.
None of the 7 checks that could run raised a question.
No. FinMinutes reports what was filed and the questions the numbers raise. It does not recommend buying, selling or holding any security.
Numbers as filed with the exchanges, read by rules. Every flag is a question with its source, not an accusation. FinMinutes is a financial data and analytics platform; nothing here is a recommendation to buy, sell or hold any security. How each check works.